ArticleBMC cancer2019

The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.

Pablo Fernández-Navarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.